Related Experiment Video
Updated: Dec 24, 2025

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and
Donglim Esther Park1,2, Jingwei Cheng2,3, John P McGrath4
1Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA.
Abstract:
Merkel cell carcinoma (MCC)-a neuroendocrine cancer of the skin-is caused by the integration of Merkel cell polyomavirus and persistent expression of large T antigen and small T antigen. We report that small T antigen in complex with MYCL and the EP400 complex activates the expression of LSD1 (KDM1A), RCOR2 and INSM1 to repress gene expression by the lineage transcription factor ATOH1. LSD1 inhibition reduces the growth of MCC in vitro and in vivo. Through a forward-genetics CRISPR-Cas9 screen, we identified an antagonistic relationship between LSD1 and the non-canonical BAF (ncBAF) chromatin remodelling complex. Changes in gene expression and chromatin accessibility caused by LSD1 inhibition were partially rescued by BRD9 inhibition, revealing that LSD1 and ncBAF antagonistically regulate an overlapping set of genes. Our work provides mechanistic insight into the dependence of MCC on LSD1 and a tumour suppressor role for ncBAF in cancer.
Insights
Merkel cell carcinoma (MCC) growth depends on LSD1, a protein targeted for inhibition. The non-canonical BAF complex antagonizes LSD1, suggesting a potential therapeutic strategy for this skin cancer.
Area of Science:
- Oncology
- Molecular Biology
- Virology
Background:
- Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer linked to Merkel cell polyomavirus.
- Viral T antigens drive MCC pathogenesis by altering host gene expression.
Purpose of the Study:
- To elucidate the molecular mechanisms driving MCC proliferation.
- To identify novel therapeutic targets for MCC treatment.
Main Methods:
- Investigated the role of viral small T antigen in regulating gene expression.
- Utilized CRISPR-Cas9 screening to identify genetic interactions.
- Assessed the effects of LSD1 and BRD9 inhibition on MCC cell growth and gene expression.
Main Results:
- Viral small T antigen complex activates LSD1 (KDM1A) expression, which represses the lineage transcription factor ATOH1.
- LSD1 inhibition significantly reduces MCC tumor growth in vitro and in vivo.
- A forward-genetics screen revealed an antagonistic relationship between LSD1 and the non-canonical BAF (ncBAF) chromatin remodeler.
- BRD9 inhibition partially rescued gene expression and chromatin accessibility changes induced by LSD1 inhibition.
Conclusions:
- MCC is mechanistically dependent on LSD1 for tumor growth.
- LSD1 and ncBAF antagonistically regulate overlapping gene sets in MCC.
- ncBAF complex exhibits tumor suppressor functions in MCC, presenting a potential therapeutic avenue.
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
MAPK Signaling Cascades
Induced Pluripotent Stem Cells
Somatic...
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

